CardioDx strikes deal to bring artery disease assay to India

04/26/2013 | GenomeWeb Daily News (free registration)

CardioDx has agreed to allow Core Diagnostics India to distribute its Corus CAD diagnostic system in India for undisclosed terms. The blood-based gene expression test, which was released as a laboratory-developed assay in 2009, is intended to screen patients showing symptoms of obstructive coronary artery disease.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT